Ni02113 PDF
Ni02113 PDF
Ni02113 PDF
net/publication/43555094
CITATIONS READS
0 1,793
3 authors, including:
Some of the authors of this publication are also working on these related projects:
Role of blood biomarkers in predicting outcomes after acute stroke View project
All content following this page was uploaded by Rohit Bhatia on 05 June 2014.
Tetanus
Summary
Tetanus is a potentially life threatening disease affecting nearly 50,000 to 1 million people
world wide every year. Four major clinical forms of tetanus are described i.e. generalized,
cephalic, localized and neonatal. Neonatal tetanus is particularly common in developing
countries, due to unhygienic child birth practices, social taboos and improper
immunization of pregnant mothers. Management of this disorder involves a team
approach and aims at eradicating focus of infection, neutralizing the toxin, controlling
spasms and dysautonomia and providing adequate ventilatory and supportive care.
Metronidazole may be the preferred antibiotic although penicillin is still used frequently.
Adequate wound debridement is necessary to prevent spore germination. Spasms are
usually managed by sedatives like diazepam and neuromuscular blocking agents.
Magnesium sulphate is an attractive substitute and may be tried if ventilatory facilities are
unavailable. Use of baclofen is potentially advantageous but cannot be routinely
prescribed. Dysautonomia is difficult to manage and requires therapy with
benzodiazepines, morphine, magnesium sulphate, adrenergic blockers and recently tried
baclofen therapy. Supportive care including ventilatory assistance are highly essential for
successful outcome of the patients. It is imperative that complications are diagnosed early
and managed appropriately. Immunization is extremely effective and is the key to
prevention. Adequate steps and measures should be taken to increase awareness of this
potentially preventable disease.
Tetanus is a potentially fatal disease manifesting itself ‘clostridium tetani’. Despite the availability of a
as painful spasms, autonomic instability and highly effective vaccine, nearly 1 million cases of
respiratory compromise, caused by ‘tetanospasmin’ a tetanus occur worldwide every year.1 Majority of the
potent neurotoxin liberated by the organism tetanus related deaths occur in Africa and South-east
Asia, and the disease remains endemic in many
Correspondence to : Dr. S. Prabhakar, Professor and Head,
Department of Neurology, Postgraduate Institute of Medical countries worldwide.2 The present review deals with a
Education and Research, Chandigarh - 160 012, India. brief overview of the disease, available treatment
E-mail: [email protected] options and methods of prevention.
Brief History and Epidemiology but are destroyed by autoclaving at 1200C for 15
minutes or boiling for atleast 4 hours. The vegetative
The clinical descriptions of tetanus are available in form produces ‘tetanospasmin’, a potent neurotoxin
records from antiquity (5th Century BC). In the year which is responsible for the clinical manifestations
1884, Nicolaier produced tetanus in animals by and ranks second to the botulinum toxin as the most
injecting them with soil specimens. Kitasato isolated potent microbial toxin known.7
the organism in 1889 from a human tetanus victim and
reported neutralization of toxin by specific antibodies. Pathogenesis
Tetanus toxoid was described by Descombey in 1924
and was effectively used during the world war II. The Under anaerobic conditions, spores present around the
global incidence of tetanus is about 18 cases per wound germinate. This leads to production of two
100,000 population per year, with case fatality known toxins : ‘tetanospasmin’ and ‘tetanolysin’,
ranging between 20 and 50%. In places like USA, the which are disseminated by blood and lymphatics to
incidence of this disease has dramatically reduced several sites within the nervous system. Tetanolysin
over years whereas in developing countries it is still has a uncertain role and major clinical effects of the
observed frequently. At least 40-50% of deaths occur disease are secondary to the action of tetanospasmin.
in neonates, especially due to unhygienic conditions The toxin is produced as a polypeptide but undergoes
during birth and social practices like smearing cow post-translational cleavage into two di-sulfide linked
dung or ghee (clarified butter) on umbilical stump.3 fragments, the light (L) and heavy (H) chains.2 The H
During a tetanus surveillance from USA between chain mediates attachment to gangliosides in
1995-1997, 60% of cases were between 20-59 years peripheral nerves and subsequently the toxin is
of age, whereas in prior reports, population above 60 internalized and moves to the CNS by retrograde
years was more commonly affected.4 Punctures, axonal transport and trans-synaptic spread. Once
lacerations, and abrasions accounted for 64% of inside the CNS, the ‘L’ chain mediated cleavage of
reported cases. The higher risk in elderly is possibly synaptobrevin (an essential component of synaptic
related to a decline in protective levels of antibodies vessels needed for fusion and release of
with ageing and therefore a booster dose of neurotransmitters) prevents presynaptic release of
vaccination is recommended every 10 years to ensure inhibitory neurotransmitter γ-aminobutyric acid
protection.5 Almost all reported cases of tetanus are in (GABA) and glycine, causing sustained excitatory
patients who either have never been vaccinated, or discharge of disinhibited α-motor neurons and muscle
who completed a primary series, but have not had a spasms of tetanus. The toxin exerts its effects on the
booster in the preceding ten years. Although the spinal cord, brain stem, peripheral nerves,
incidence of tetanus is grossly underreported in India, neuromuscular junctions, and directly on muscles.2
it has shown a downward trend due to the national The rapidity of incubation and onset correlates with
immunization programme.6 Considering the severity of the disease. Recovery involves synthesis of
seriousness of this disorder, adequate wound hygiene new presynaptic components and their transport to
and thorough immunization practices are warranted to distal axon,8 accounting for the delay of 2-3 weeks
prevent the occurrence of this potentially fatal disease. before clinical improvement begins.1
monitoring throughout the illness. Ventilatory immunogenecity and a longer half life of 24-31 days.
assistance, respiratory failure, renal dysfunction, The equine formulation has a high likelihood of
autonomic imbalance and complications of prolonged anaphylactic reactions and has a half life of only 2
critical illness like nosocomial infections, sepsis, days. The usual dose of equine preparation is 500-
thromboembolism and gastrointestinal hemorrhage 1000 IU/kg given intravenously or intramuscularly.
need special attention.2 The defined goals of treatment The dose of HTIG is 5000-8000 IU intramuscularly.
include the following : a) halting production of toxin Local infiltration around the wound is not
within the wound, b) neutralization of unbound toxin, recommended presently. Usual dose for prophylaxis is
c) control of muscle spasms, d) management of 1500-3000 IU of equine and 250-500 IU of human
autonomic instability, e) supportive therapy, preparation.2 The blood concentration of antitoxin for
f) management of complications, g) prevention. protection against tetanus is 0.1 IU/ml. Intrathecal
therapy with antitoxin has been tried in the past, but a
a) Halting the production of toxin meta-analysis of the same showed no obvious benefit
of such a therapy.29
(i) Wound management : Debridement of a wound is
important to eradicate spores and change conditions (c) Control of muscle spasms
for germination, thereby preventing further
elaboration and absorption of the neurotoxin. Wound Spasms in tetanus are potentially life threatening, for
characteristics strongly correlate with the they impair respiratory function, produce exhaustion
development of tetanus. Recent linear wounds with and often lead to aspiration of gastric contents. Many
sharp edges that are well vascularised and not drugs have been used for the effective control of
obviously infected are usually non-tetanus prone. All spasms in tetanus patients. Sedation has been the
other wounds are considered potentially predisposed, mainstay in the past and is still used as the primary
especially those that have resulted from blunt trauma, therapy in most of the centres for its easy availability.
bites and are obviously contaminated.1 However, use of muscle relaxants is frequent in
intensive units and sedation is used as a adjunct to
(ii) Antibiotic therapy : Penicillin and metronidazole management.
are the two major drugs used routinely. Penicillin still
remains a standard therapy in many parts of the world, Sedatives : Benzodiazepines have been traditionally
although metronidazole seems to be replacing it and is used for control of spasms. Diazepam is the most
being considered as a drug of choice by many.1,2,12,25 commonly used drug of this class, and is usually the
Metronidazole has a better safety profile, better tissue first drug to be used in the initial phase of the illness.
penetrability and negligible CNS excitability The doses used have been variable, depending upon
(penicillin can cause seizures at high doses). It can the patients clinical condition and response. The
also be given rectally which minimizes and reduces average dose used as an adjunct to muscle relaxants is
frequency of spasms, which otherwise would be 10-30 mg 6-8 hrly, and is usually the starting dose
precipitated by an I/V or I/M medication. Ahmadsyah even when used solely. Doses upto 120 mg/kg/day
and Salim26 showed improvement in mortality with have also been used.30 Respiratory depression and
use of metronidazole but Yen et al27 and Singhi et al28 prolonged sedation are major problems at high doses
did not report the same benefit. However, where and appropriate ventilatory assistance is imperative.
available, metronidazole should be the preferred Midazolam has been used with beneficial effects but is
antibiotic. The usual dose of penicillin is 100,000 – expensive and needs more respiratory assistance.
200,000 IU/kg/day given intravenously or However, its relative short duration of action and early
intramuscularly. Metronidazole is used at a dose of reversability of sedation are distinct advantages over
500 mg every 6 hours intravenously or per orally and diazepam therapy.31,32 It is imperative to titrate doses
400 mg rectally every 6 hours, for 7-10 days. gradually for the risk of sedation, respiratory
depression and accumulation of metabolites.33 The
(b) Neutralization of the unbound toxin drug should be tapered gradually to avoid withdrawl
reactions. Propofol, a general anesthetic, has been
This is achieved through passive immunization with used with benefit in control of spasms and rigidity,34
either human or equine tetanus immunoglobulin. This and has been corroborated with neurophysiological
should be undertaken as early as possible since the studies.12 Adverse effects include hypotension,
toxin becomes inaccessible once it is bound to the bradycardia, pain at injection site, hypertriglyceri-
nerve terminus. Human tetanus immunoglobulin demia, pancreatic dysfunction and need for
(HTIG) is the preferred form because of lack of mechanical ventilation.33 Prolonged use of propofol
(>48 hrs) has been associated with lactic acidosis, ease of administration, availability of experience in
bradycardia and lipemia in children and is therefore managing patients with eclampsia, and avoidance of
not recommended for pediatric use.33 It is strongly sedation and mechanical ventilation, the drug seems
recommended that propofol infusion bottles and definitely advantageous in management of tetanus
tubing should be hanging for no more than 12 hours related spasms. However, more trials and experience
and solution transferred from main vial be discarded with the use of this drug is required. It is usually given
after 6 hours for the risk of bacterial overgrowth and as a loading dose of 5 gm over 20 minutes followed by
nosocomial infections. a regular infusion at a rate of 2 gm/hour. Abolition of
patellar reflex is taken as the endpoint and evidence
(ii) Neuromuscular blocking agents : The use of these of hypocalcemia is judged by positive Chvostek’s and
drugs becomes imminent, when sedation produces no Trousseau’s signs. The drug is best avoided in the
benefit. However, intubation with positive pressure presence of severe renal failure.
ventilation is mandatory. Commonly, pancuronium
has been widely used for its lesser cost. However, (iv) Baclofen : Baclofen, a physiological GABA
potential risk of worsening autonomic dysfunction is agonist has been used in few small studies for
present because of its effects on catecholamine effective control of tetanic spasms.40-43 The drug
uptake. Vecuronium is considered the drug of choice inhibits mono and polysynaptic medullary reflexes,
because of negligible cardiovascular effects, but is resulting in a antispastic action.43 It has been shown to
short acting and cost is a limiting factor. It has a stimulate postsynaptic GABA β receptors, thereby
potential risk of accumulation in presence of renal restoring physiological inhibition of α motor neurons.
failure. Recuronium is highly safe but expensive. High dose intrathecal baclofen has been used for the
Monitoring of patients on muscle relaxant therapy is treatment of tetanus induced contractures and spasms,
difficult and it is important that doses of relaxants be thereby limiting the need for general anesthesia and
spaced out after 2 weeks and usually stopped after intubation in afflicted patients.40 The preferred route
three weeks to prevent complications and adverse of administration is intrathecal for the drug is 600
effects on long term use. Prolonged recovery from times more potent at a much lesser dose compared to
paralysis is thought to be related to accumulation of the oral route. The half life of this drug is between 0.9
drugs or their metabolites. Acute quadriplegic to 5 hours. The largest series published is by Engrad
myopathy syndrome or AQMS is common when et al43 who have reported 14 patients treated with this
steroids are taken concomitantly and reports of this regimen, of which it was effective in twelve. However,
dysfunction with use of neuromuscular blocking baclofen has a narrow therapeutic range and a large
drugs alone is uncommon.35 It usually presents as a interindividual pharmacodynamic variability. The cost
acute paresis with myonecrosis, increased CPK and of therapy and need for surgical expertise (in case
abnormal EMG. Other potential hazards with use of infusion pump is required), are major deterrents for its
these drugs is muscle contractures, atrophy and risk of use. The dose is variable and on an average is about
venous thrombosis or embolic events related to 1000 mcg in adults below 55 years, 500 mcg below 16
immobility. Pancuronium may be a safe option to start years of age and 800 mcg for adults above 55 years.
with if no cardiovascular dysfunction is present. In Intermittent boluses may be given initially at an
presence of severe hepatic or renal disease, interval of 10-20 hours depending upon the response
cisatracuronium or atracuronium may be used.36 Eye of the patient or it may be given by a continuous
care is essential and concomitant use of steroids is infusion if frequent doses are necessary. Caution is
discouraged. desired in patients with severe dysautonomia and
when spasticity is used to obtain increased function.
(iii) Magnesium sulfate : Role of magnesium sulfate in
the management of tetanus has been postulated by (v) Dantrolene : It is a directly acting muscle relaxant
many authors.37,38 Blake treated two patients of mediating its action through inhibition of calcium
tetanus with intrathecal magnesium sulfate, as early as release by sarcoplasmic reticulum and thereby
1906.39 Magnesium physiologically antagonizes directly affecting excitation contraction coupling. It
calcium and there is a correlation between depression has been used in isolated cases in the past for
of neuromuscular transmission and serum magnesium managing tetanic spasms and has the major benefit of
concentrations.37 Use of magnesium sulfate has the not requiring artificial ventilation. However, the drug
added advantage of controlling dysautonomia, where is expensive and cannot be recommended for routine
it has been more commonly used. Considering the use.
15. Kakou AR, Eholic S, Ehui E et al : Localised tetanus in 36 Murray MJ, Cowen J, DeBlock H et al : Clinical practice
Abidjan : Clinical and prognostic features (1976-1997). Bull guidelines for sustained neuromuscular blockade in adult
Soc Pathol Exot 2001; 94 : 308-311. critically ill patients. Crit Care Med 2002; 30 : 142-156.
16. Jagoda A, Riggio S, Burgieres T : Cephalic tetanus : A case 37. Attygalle D, Rodrigo N : Magnesium sulfate for control of
report and review of literature. Am J Emerg Med 1988; 6 : spasms in severe tetanus. Can we avoid sedation and
128-130. artificial ventilation? Anaesthesia 1997; 52 : 952-962.
17. Vakil BJ, Singhal BS, Pandya SS et al : Cephalic tetanus. 38. Attagylle D, Rodrigo N : Magnesium sulfate for the control
Neurology 1973; 23 : 190-196. of spasms in severe tetanus. Anaesthesia 1999; 54 : 302-
18. Patel JC, Kale PA, Mehta BC : Otogenic tetanus - Study of 303.
922 cases. In : Proceedings of an international conference 39. Blake JA : The use of magnesium sulfate in the production
on Tetanus. Patel JC (ed). Bombay. 1965; 640-644 of anaesthesia and in the treatment of tetanus. Surgical
19. Nida H : Neonatal tetanus in Awassa. Retrospective Gynaecology and Obstetrics 1906; 2 : 541-550.
analysis of patients admitted over 5 years. Ethiop Med J 40. Engrand N, Vilain G, Rouamba A et al : Value of intrathecal
2001; 39 : 241-246. baclofen in the treatment of severe tetanus in the tropical
20. Phillips LA : A classification of tetanus. Lancet 1967; 1 : milieu. Med Trop 2000; 60 : 385-388.
1216-1217. 41. Boots RJ, Lipman J, O’Lallagan J et al : The treatment of
21. Ablett JJL : Analysis and main experiences in 82 patients tetanus with intrathecal baclofen. Anaesth Intensive Care
treated in the Tetanus unit. In : Symposium on tetanus in 2000; 28 : 438-442.
great Britain. Ellis M (ed). Boston Spa, National Lending 42. Engrand N, Van De Perre P et al : Intrathecal baclofen for
Library, U.K. 1967; 1-10. severe tetanus in a pregnant woman. Eur J Anaesthesiol
22. Prabhakar S, Singh G, Chopra JS et al : Peripheral 2001; 18 : 261-263.
neuropathy in tetanus : A clinical, neuroelectrophysiological 43. Engrand N, Guerot E, Rouamba A et al : The efficacy of
and histological evaluation. Neurol Ind 1997; 45 : 81-86. intrathecal baclofen in severe tetanus. Anesthesiology
23. Apte NM, Karnad DR : Short report - the spatula test : a 1999; 90 : 1773-1776.
single bedside test to diagnose tetanus. Am J Trop Med 44. Prys-Roberts C, Corbett JL, Kerr JH et al : Treatment of
Hyg 1995; 53 : 386-387. sympathetic overactivity in tetanus. Lancet 1969; 1 : 542.
24. Dastur FD : Emergency treatment of tetanus. JAPI 1997; 45. Rocke DA, Pather M, Calver AD et al : Morphine in tetanus
(suppl 2) : 44-46. – the management of sympathetic nervous system
25. Garlicki A, Caban J, Bociaga JM et al : Modifications in overactivity. S Afr Med J 1986; 70 : 666-668
treatment of tetanus and prognosis : Observations from the 46. Bhagwanjee S, Bosenberg AT, Muckart DJT : Management
Gacon Department of Infectious Diseases. Przegl Lek of sympathetic overactivity in tetanus with epidural
1999; 56 : 566-567. bupivacaine and sufentanil. Experience with 11 patients.
26. Ahmadsyah I, Salim A : Treatment of tetanus : An open Crit Care Med 1999; 27 : 1721-1725.
study to compare the efficacy of procaine penicillin and 47. Wesley AG, Hariprasad D, Pather M et al : Labetalol in
metronidazole. BMJ 1985; 291 : 648-650. tetanus. The treatment of sympathetic nervous system
27. Yen LM, Dao LM, Day NPJ et al : Management of tetanus : overactivity. Anaesthesia 1983; 38 : 243-249.
A comparison of penicillin and metronidazole. Symposium 48. Gregorakos L, Kerezoudi E, Dimopoulos G et al :
of antimicrobial resistance in Southern Vietnam . 1997. Management of blood pressure instability in severe tetanus
28. Singhi S, Jain V, Subramanian C : Post-neonatal tetanus : : the use of clonidine. Intensive Care Med 1997; 23 : 893-
Issues in intensive care management. Indian J Pediatr 894.
2001; 68 : 267-272. 49. James MFM, Manson EDM : The use magnesium infusions
29. Abrutyn E, Berlin JA : Intrathecal therapy in tetanus : a in management of very severe tetanus. Intensive Care
meta-analysis. JAMA 1991; 226 : 2262-67. Medicine 1985; 11 : 5-12.
30. Al-Kaabi JM, Scrimgeour EM, Louon A et al : Tetanus : A 50. Lipman J, James MFM, Esskire J et al : Autonomic
clinical review. Saudi Med J 2001; 22 : 606-609. dysfunction in severe tetanus : magnesium sulfate as an
31. Gyasi HK, Fahr J, Kurian et al : Midazolam for prolonged adjunct to deep sedation. Crit Care Med 1987; 15 : 987-988.
intravenous sedation in patients with tetanus. Middle East J 51. Halliday PL, Bauer RB : Polyradiculitis secondary to
Anesth 1993; 12 : 135-141. immunization with tetanus and diphtheria toxoids. Arch
32. Tobias JD : Anesthetic implications of tetanus. South Med J Neurol 1983; 40 : 56-57.
1998; 91 : 384-87. 52. Schwendeman SP, Tobio M, Joworonicz M et al : New
33. Jacobi J, Fraser GL, Coursin DB et al : Clinical practice strategies for the microencapsulation of tetanus vaccine.
guidelines for the sustained use of sedatives and J Microencapsul 1998; 15 : 299-318.
analgesics in the critically ill adult. Crit Care Med 2002; 30 53. Grover VK, Gupta S, Sharma S et al : Management of
: 117-141. tetanus : a review of 100 consecutive cases. J Anaesth Clin
34 Borgeat A, Popovic V, Schwander D : Efficacy of a Pharmcol 1992; 10 : 23-27.
continuous infusion of propofol in a patient with tetanus. Crit 54. Lau LG, Kong KO, Chew PH : A ten year retrospective
Care Med 1991; 19 : 295-297. study of tetanus at a general hospital in Malaysia.
35. Doxacurium – corticosteroid acute myopathy : another Singapore Med J 2001; 42 : 346-350.
piece to the puzzle. Crit Care Med 1996; 24 : 1266-1267.
Accepted for publication : 20th August, 2002.